208 related articles for article (PubMed ID: 32477338)
21. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
[TBL] [Abstract][Full Text] [Related]
22. Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses.
Xiao H; Ulmert I; Bach L; Huber J; Narasimhan H; Kurochkin I; Chang Y; Holst S; Mörbe U; Zhang L; Schlitzer A; Pereira CF; Schraml BU; Baumjohann D; Lahl K
Nat Commun; 2024 Apr; 15(1):3554. PubMed ID: 38688934
[TBL] [Abstract][Full Text] [Related]
23. Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.
Kalim KW; Yang JQ; Wunderlich M; Modur V; Nguyen P; Li Y; Wen T; Davis AK; Verma R; Lu QR; Jegga AG; Zheng Y; Guo F
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36427906
[TBL] [Abstract][Full Text] [Related]
24. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
25. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
26. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function.
Sawant DV; Sehra S; Nguyen ET; Jadhav R; Englert K; Shinnakasu R; Hangoc G; Broxmeyer HE; Nakayama T; Perumal NB; Kaplan MH; Dent AL
J Immunol; 2012 Nov; 189(10):4759-69. PubMed ID: 23053511
[TBL] [Abstract][Full Text] [Related]
27. GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer.
Adamczyk A; Pastille E; Kehrmann J; Vu VP; Geffers R; Wasmer MH; Kasper S; Schuler M; Lange CM; Muggli B; Rau TT; Klein D; Hansen W; Krebs P; Buer J; Westendorf AM
Cancer Res; 2021 Jun; 81(11):2970-2982. PubMed ID: 33727229
[TBL] [Abstract][Full Text] [Related]
28. T Follicular Regulatory Cells: Choreographers of Productive Germinal Center Responses.
Lu Y; Craft J
Front Immunol; 2021; 12():679909. PubMed ID: 34177925
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.
Eschweiler S; Clarke J; Ramírez-Suástegui C; Panwar B; Madrigal A; Chee SJ; Karydis I; Woo E; Alzetani A; Elsheikh S; Hanley CJ; Thomas GJ; Friedmann PS; Sanchez-Elsner T; Ay F; Ottensmeier CH; Vijayanand P
Nat Immunol; 2021 Aug; 22(8):1052-1063. PubMed ID: 34168370
[TBL] [Abstract][Full Text] [Related]
30. Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8
Liu C; Chikina M; Deshpande R; Menk AV; Wang T; Tabib T; Brunazzi EA; Vignali KM; Sun M; Stolz DB; Lafyatis RA; Chen W; Delgoffe GM; Workman CJ; Wendell SG; Vignali DAA
Immunity; 2019 Aug; 51(2):381-397.e6. PubMed ID: 31350177
[TBL] [Abstract][Full Text] [Related]
31. Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity.
Cheng L; Deng N; Yang N; Zhao X; Lin X
J Immunol; 2019 May; 202(10):3008-3019. PubMed ID: 30979818
[TBL] [Abstract][Full Text] [Related]
32. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
33. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
34. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.
Watson MJ; Vignali PDA; Mullett SJ; Overacre-Delgoffe AE; Peralta RM; Grebinoski S; Menk AV; Rittenhouse NL; DePeaux K; Whetstone RD; Vignali DAA; Hand TW; Poholek AC; Morrison BM; Rothstein JD; Wendell SG; Delgoffe GM
Nature; 2021 Mar; 591(7851):645-651. PubMed ID: 33589820
[TBL] [Abstract][Full Text] [Related]
35. Antitumor CD8 T cell responses in glioma patients are effectively suppressed by T follicular regulatory cells.
Lu L; Sun J; Su H; Luo S; Chen J; Qiu S; Chi Y; Lin J; Xu X; Zheng D
Exp Cell Res; 2021 Oct; 407(2):112808. PubMed ID: 34508744
[TBL] [Abstract][Full Text] [Related]
36. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
Wang H; Franco F; Tsui YC; Xie X; Trefny MP; Zappasodi R; Mohmood SR; Fernández-García J; Tsai CH; Schulze I; Picard F; Meylan E; Silverstein R; Goldberg I; Fendt SM; Wolchok JD; Merghoub T; Jandus C; Zippelius A; Ho PC
Nat Immunol; 2020 Mar; 21(3):298-308. PubMed ID: 32066953
[TBL] [Abstract][Full Text] [Related]
37. Targeting Treg cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
39. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
Torphy RJ; Sun Y; Lin R; Caffrey-Carr A; Fujiwara Y; Ho F; Miller EN; McCarter MD; Lyons TR; Schulick RD; Kedl RM; Zhu Y
Nat Commun; 2022 Jan; 13(1):97. PubMed ID: 35013216
[TBL] [Abstract][Full Text] [Related]
40. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer.
Overacre-Delgoffe AE; Bumgarner HJ; Cillo AR; Burr AHP; Tometich JT; Bhattacharjee A; Bruno TC; Vignali DAA; Hand TW
Immunity; 2021 Dec; 54(12):2812-2824.e4. PubMed ID: 34861182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
